Skip to main content
logo
Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada flag Canada · Delayed Price · Currency is CAD
0.0900
0.00 (0.00%)
Aug 7, 2026, 5:22 PM EST

Rapid Dose Therapeutics Financials Overview

Millions CAD. Fiscal year is Mar - Feb.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMay '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Revenue
2.582.772.091.020.721.75
Revenue Growth
4.30%33.00%104.34%42.06%-59.00%131.98%
Gross Profit
1.281.361.180.560.361.34
Operating Income
-1.89-2.17-4.17-3.09-3.54-4.3
Net Income
-3.17-3.39-5.4-4.31-3.81-8.49
Earnings Per Share
-0.02-0.03-0.04-0.04-0.04-0.08
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMay '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Cash & Investments
0.010.010.020.160.030.03
Total Debt
5.815.322.612.452.121.43
Net Cash (Debt)
-5.79-5.31-2.59-2.29-2.1-1.4
Net Cash Growth
------
Net Cash Per Share
-0.04-0.04-0.02-0.02-0.02-0.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMay '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Operating Cash Flow
0.21-0.27-1.15-2.29-0.86-3
Capital Expenditures
--0-0.01---0.04
Free Cash Flow
0.21-0.27-1.15-2.29-0.86-3.04
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMay '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Gross Margin
49.83%49.15%56.59%55.21%49.67%76.76%
Operating Margin
-73.58%-78.29%-200.07%-302.45%-493.36%-245.55%
Pretax Margin
-123.09%-122.22%-259.18%-422.03%-530.42%-484.47%
Profit Margin
-123.09%-122.23%-259.18%-422.03%-530.42%-484.47%
FCF Margin
8.18%-9.78%-55.27%-224.91%-120.27%-173.52%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
PS Ratio
4.777.3110.5620.2012.9815.10